US/UK/Canada

Share

Pick a time period -
Tags ( Active)

HDR Partners divests Hermes Medical Solutions to Segulah

HDR Partners Corporate Finance has advised Hermes Medical Solutions in the divestment to SegulahHermes Medical Solutions provides systems and software for integrating, visualizing, processing and archiving multi-format imaging data from scanning devices within molecular imaging and radi-ology. The systems are primarily used by physicians enabling faster and more accurate diagnosis and treatment of patients, thereby increasing efficiency for hospitals. Hermes is vendor-neutral and can integrate data from any scanning device (e.g. PET, CT, MRI and SPECT) irrespective of man-ufacturer or model,

HDR Partners Corporate Finance has successfully completed the divestment of Inet AB to Creades AB (publ)

HDR Partners is proud to have advised Inet in conjunction with its divestment to Creades. Inet’s management team is excited about the opportunity to continue developing the business with the new owners. Creades will own 70% and the founders of Inet will own the remaining 30%. Inet’s enterprise value is SEK 135 million and Creades invests SEK 80 million to enable continued store expansion and growth in e-commerce. Inet is a leading omni-channel retailer on the Swedish Home and Personal PC hardware market, focusing on Dedicated PC users. The Company has established a highly loyal customer

ABG Sundal Collier and HDR Partners advisors as NeuroVive completes a directed share issue of SEK 65 million

NeuroVive Pharmaceutical AB (publ) (”NeuroVive” or the “Company”, OMX:NVP) today announces that the Company has completed a directed share issue of 1.3 million new shares, which brings SEK 65 million to the Company before transaction costs.The new share issue, which was approved by the board of the Company on 19 February 2015 with authorization from the Annual General Meeting on 9 May 2014, includes 1,300,000 new shares and has been directed to a limited group of Swedish and international institutional qualified investors at a price of SEK 50 per share through a private placement procedure.

There are no items matching the current filter
There are no more items matching the current filter
Back to top